In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer
✍ Scribed by Emmanuelle N. Sabbah; Jean Kadouche; David Ellison; Ciara Finucane; Didier Decaudin; Stephen J. Mather
- Book ID
- 116799077
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 666 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0969-8051
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A challenge in photodynamic therapy (PDT) is to improve the tumour selectivity of the photosensitizers by using monoclonal antibodies (MAbs). With this aim, we developed MAb‐conjugates with the hydrophobic photosensitizer __meta__‐tetrahydroxyphenylchlorin (__m__THPC) and with the hydro
## Abstract New tumor‐specific contrast agents for clinical imaging and therapy for cancer are required. To this end Gd‐H (Gd‐hematoporphyrin), Gd‐TCP (Gd‐tetra‐carboranylmethoxyphenyl‐porphyrin), Gd‐DTPA‐WM53, and Gd‐DTPA‐9.2.27 were synthesized and administered by systemic injection to nude mice